Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon J Freeman

Showing results (51-60 of 348) with videos related to

Pageof 35
Sort By:
Investigative Ophthalmology & Visual Science|December 19, 2009
Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammationJaafar El Annan, Sunali Goyal, Qiang Zhang, et al.
Nature Immunology|January 15, 2008
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediatorGuifang Cai, Anukanth Anumanthan, Julia A Brown, et al.
Immunity|July 17, 2007
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responsesManish J Butte, Mary E Keir, Theresa B Phamduy, et al.
Blood|December 14, 2006
Twisted gastrulation (Tsg) is regulated by Tob and enhances TGF-beta signaling in activated T lymphocytesDimitrios Tzachanis, Lequn Li, Esther M Lafuente, et al.
Journal of Neuro-Oncology|March 4, 2025
Improving IL12 immunotherapy in glioblastoma by targeting the long noncoding RNA INCR1Shikha Saini, Josephina A M A Gadet, Gordon J Freeman, et al.
AIDS (London, England)|September 22, 2007
PD-1 expression on human CD8 T cells depends on both state of differentiation and activation statusDelphine Sauce, Jorge R Almeida, Martin Larsen, et al.
Immuno-Oncology Insights|May 3, 2023
Preclinical models for development of immune-oncology therapiesYufei Wang, Sarah E Shelton, Gabriella Kastrunes, et al.
Oncoimmunology|July 9, 2015
Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expressionRoberto Bellucci, Allison Martin, Davide Bommarito, et al.
Plos One|November 9, 2013
PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loadsEdward Seung, Timothy E Dudek, Todd M Allen, et al.
Cellular Immunology|December 16, 2004
PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cellsGuifang Cai, Arnon Karni, Enedina M L Oliveira, et al.
Pageof 35

Showing results (51-60 of 348) with videos related to

Sort By:
Pageof 35
Investigative Ophthalmology & Visual Science|December 19, 2009
Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammationJaafar El Annan, Sunali Goyal, Qiang Zhang, et al.
Nature Immunology|January 15, 2008
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediatorGuifang Cai, Anukanth Anumanthan, Julia A Brown, et al.
Immunity|July 17, 2007
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responsesManish J Butte, Mary E Keir, Theresa B Phamduy, et al.
Blood|December 14, 2006
Twisted gastrulation (Tsg) is regulated by Tob and enhances TGF-beta signaling in activated T lymphocytesDimitrios Tzachanis, Lequn Li, Esther M Lafuente, et al.
Journal of Neuro-Oncology|March 4, 2025
Improving IL12 immunotherapy in glioblastoma by targeting the long noncoding RNA INCR1Shikha Saini, Josephina A M A Gadet, Gordon J Freeman, et al.
AIDS (London, England)|September 22, 2007
PD-1 expression on human CD8 T cells depends on both state of differentiation and activation statusDelphine Sauce, Jorge R Almeida, Martin Larsen, et al.
Immuno-Oncology Insights|May 3, 2023
Preclinical models for development of immune-oncology therapiesYufei Wang, Sarah E Shelton, Gabriella Kastrunes, et al.
Oncoimmunology|July 9, 2015
Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expressionRoberto Bellucci, Allison Martin, Davide Bommarito, et al.
Plos One|November 9, 2013
PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loadsEdward Seung, Timothy E Dudek, Todd M Allen, et al.
Cellular Immunology|December 16, 2004
PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cellsGuifang Cai, Arnon Karni, Enedina M L Oliveira, et al.
Pageof 35